215 related articles for article (PubMed ID: 954351)
1. Influence of viral hepatitis on the disposition of two compounds with high hepatic clearance: lidocaine and indocyanine green.
Williams RL; Blaschke TF; Meffin PJ; Melmon KL; Rowland M
Clin Pharmacol Ther; 1976 Sep; 20(3):290-9. PubMed ID: 954351
[TBL] [Abstract][Full Text] [Related]
2. Effects of smoking and chronic hepatitis B on lidocaine and indocyanine green kinetics.
Huet PM; Lelorier J
Clin Pharmacol Ther; 1980 Aug; 28(2):208-15. PubMed ID: 7398188
[TBL] [Abstract][Full Text] [Related]
3. Lidocaine kinetics predicted by indocyanine green clearance.
Zito RA; Reid PR
N Engl J Med; 1978 May; 298(21):1160-3. PubMed ID: 651945
[TBL] [Abstract][Full Text] [Related]
4. Lidocaine kinetics: relationships between early lidocaine kinetics and indocyanine green clearance.
Zito RA; Reid PR
J Clin Pharmacol; 1981; 21(2):100-5. PubMed ID: 7229115
[TBL] [Abstract][Full Text] [Related]
5. Effect of portacaval shunt on drug disposition in patients with cirrhosis.
Pomier-Layrargues G; Huet PM; Villeneuve JP; Marleau D
Gastroenterology; 1986 Jul; 91(1):163-7. PubMed ID: 3710065
[TBL] [Abstract][Full Text] [Related]
6. Effect of H2-receptor antagonists on steady-state extraction of indocyanine green and lidocaine by the perfused rat liver.
Roberts RK; Heath CA; Johnson RF; Speeg KV; Schenker S
J Lab Clin Med; 1986 Feb; 107(2):112-7. PubMed ID: 2868064
[TBL] [Abstract][Full Text] [Related]
7. Lignocaine and indocyanine green kinetics in patients following myocardial infarction.
Bax ND; Tucker GT; Woods HF
Br J Clin Pharmacol; 1980 Oct; 10(4):353-61. PubMed ID: 7448106
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic study on the hepatic uptake of indocyanine green in cirrhotic patients.
Kawasaki S; Sugiyama Y; Iga T; Hanano M; Sanjo K; Beppu T; Idezuki Y
Am J Gastroenterol; 1985 Oct; 80(10):801-6. PubMed ID: 4036939
[TBL] [Abstract][Full Text] [Related]
9. Assessment of hepatic function in cystic fibrosis by lidocaine metabolism.
Gremse DA; Sindel LJ; Hoff CJ; Wells DJ; Boerth RC
J Pediatr Gastroenterol Nutr; 2001 Apr; 32(4):434-7. PubMed ID: 11396809
[TBL] [Abstract][Full Text] [Related]
10. Drug disposition in patients with HBsAg-positive chronic liver disease.
Villeneuve JP; Thibeault MJ; Ampelas M; Fortunet-Fouin H; LaMarre L; Côté J; Pomier-Layrargues G; Huet PM
Dig Dis Sci; 1987 Jul; 32(7):710-4. PubMed ID: 3595383
[TBL] [Abstract][Full Text] [Related]
11. Determinants of drug disposition in patients with cirrhosis.
Huet PM; Villeneuve JP
Hepatology; 1983; 3(6):913-8. PubMed ID: 6629320
[TBL] [Abstract][Full Text] [Related]
12. The influence of verapamil and nifedipine on hepatic indocyanine green clearance in patients with HBsAg-positive cirrhosis and ascites.
Lay CS; Tsai YT; Kong CW; Lee FY; Chang TT; Lin HC; Yang CM; Lee SD; Chiang BN; Lo KJ
Clin Pharmacol Ther; 1988 Oct; 44(4):453-7. PubMed ID: 3168396
[TBL] [Abstract][Full Text] [Related]
13. The influence of dye infusion rate and hepatic plasma flow on indocyanine green clearance.
Krarup N; Larsen JA
Scand J Clin Lab Invest; 1976 Mar; 36(2):183-8. PubMed ID: 1273495
[TBL] [Abstract][Full Text] [Related]
14. Half-life time or clearance of indocyanine green in patients with liver disease.
Gilmore IT; Marigold JH; Thompson RP
Hepatogastroenterology; 1982 Apr; 29(2):55-7. PubMed ID: 7084884
[TBL] [Abstract][Full Text] [Related]
15. The monoethylglycinexylidide test is more useful for evaluating liver function than indocyanine green test: case of a patient with remarkably decreased indocyanine green half-life.
Oda Y; Kariya N; Nakamoto T; Nishi S; Asada A; Fujimori M
Ther Drug Monit; 1995 Apr; 17(2):207-10. PubMed ID: 7624913
[TBL] [Abstract][Full Text] [Related]
16. Influence of phenobarbital on factors responsible for hepatic clearance of indocyanine green in the rat: relative contributions of induction and altered liver blood flow.
McDevitt DG; Nies AS; Wilkinson GR
Biochem Pharmacol; 1977 Jul; 26(13):1247-50. PubMed ID: 880269
[No Abstract] [Full Text] [Related]
17. The impairment of lignocaine clearance by propranolol--major contribution from enzyme inhibition.
Bax ND; Tucker GT; Lennard MS; Woods HF
Br J Clin Pharmacol; 1985 May; 19(5):597-603. PubMed ID: 2860914
[TBL] [Abstract][Full Text] [Related]
18. Thiacetarsamide in dogs: disposition kinetics and correlations with selected indocyanine green kinetic values.
Holmes RA; Wilson RC; McCall JW
Am J Vet Res; 1986 Jun; 47(6):1338-40. PubMed ID: 3729137
[TBL] [Abstract][Full Text] [Related]
19. Clearance and non-invasive determination of the hepatic extraction of indocyanine green in baboons and man.
Grainger SL; Keeling PW; Brown IM; Marigold JH; Thompson RP
Clin Sci (Lond); 1983 Feb; 64(2):207-12. PubMed ID: 6822056
[TBL] [Abstract][Full Text] [Related]
20. Normal metabolism of morphine in cirrhosis.
Patwardhan RV; Johnson RF; Hoyumpa A; Sheehan JJ; Desmond PV; Wilkinson GR; Branch RA; Schenker S
Gastroenterology; 1981 Dec; 81(6):1006-11. PubMed ID: 7286578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
